Medicare Enrolled
Dr. Edward Stark, M.D.
Urology Physician · New York, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Stark from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Stark?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Stark
Dr. Edward Stark is an urology physician in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Stark performed 2,073 Medicare services across 1,433 unique beneficiaries.
Between the years covered by Open Payments, Dr. Stark received a total of $3,832 from 41 pharmaceutical and/or device companies across 172 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Stark is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 34% volume in NY
$3,832 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,073
Medicare services
Top 34% in NY for urology physician
1,433
Unique beneficiaries
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~109 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
513 | $95 | $233 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
446 | $2 | $21 |
| PSA test (prostate cancer screening) | 229 | $18 | $109 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
199 | $60 | $165 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
89 | $8 | $78 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
74 | $245 | $488 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
63 | $5 | $179 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
62 | $18 | $109 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
56 | $121 | $350 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
49 | $72 | $241 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
47 | $54 | $696 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
39 | $43 | $185 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
34 | $20 | $85 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
31 | $8 | $17 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
23 | $15 | $212 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
23 | $67 | $236 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
19 | $25 | $111 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
17 | $24 | $82 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
16 | $95 | $606 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
16 | $22 | $85 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
15 | $19 | $88 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
13 | $282 | $2,184 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$3,832
Total received (2018-2024)
Avg $547/year across 7 years
Top 38% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
172
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,809 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$23 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$36
2023
$566
2022
$555
2021
$1,175
2020
$331
2019
$552
2018
$618
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ViiV Healthcare Company
$21
Antares Pharma, Inc.
$15
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Teleflex LLC
$587
Astellas Pharma US Inc
$373
NeoTract Inc.
$362
Dendreon Pharmaceuticals LLC
$254
Myovant Sciences Inc.
$197
AstraZeneca Pharmaceuticals LP
$174
PFIZER INC.
$173
Amgen Inc.
$167
Janssen Biotech, Inc.
$158
Endo Pharmaceuticals Inc.
$142
Sumitomo Pharma America, Inc.
$131
TOLMAR Pharmaceuticals, Inc.
$107
Blue Earth Diagnostics Limited
$71
Myriad Genetic Laboratories, Inc.
$68
Boston Scientific Corporation
$68
BOSTON SCIENTIFIC CORPORATION
$63
Merck Sharp & Dohme LLC
$60
Merck Sharp & Dohme Corporation
$59
Bayer Healthcare Pharmaceuticals Inc.
$58
Foundation Medicine, Inc.
$51
Olympus America Inc.
$49
Ferring Pharmaceuticals Inc.
$40
Antares Pharma, Inc.
$38
Alnylam Pharmaceuticals Inc.
$34
Travere Therapeutics, Inc.
$32
Avadel Specialty Pharmaceuticals, LLC
$32
MEDIVATION FIELD SOLUTIONS LLC
$32
Retrophin, Inc.
$31
Acerus Pharmaceuticals Corporation
$24
Baxter Healthcare
$24
ViiV Healthcare Company
$21
Bayer HealthCare Pharmaceuticals Inc.
$19
Supernus Pharmaceuticals, Inc.
$17
Coloplast Corp
$17
Wilmington Medical Supply, Inc.
$16
BAXTER HEALTHCARE
$16
Laborie Medical Technologies Corp.
$15
UROGEN PHARMA, INC.
$15
Janssen Pharmaceuticals, Inc
$13
Photocure Inc
$13
AbbVie, Inc.
$11
Top 3 companies account for 34.5% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AMS · AVEED · Androgel · Axumin · CYSVIEW · DOVATO · ELIGARD · ERLEADA · Erleada · FIRMAGON · FLOSEAL · FOUNDATIONONE · GENERAL BPH · JELMYTO · KEYTRUDA · LITHOVUE EMPOWER · LYNPARZA · MYRBETRIQ · Myrbetriq · Natesto · Noctiva · Nubeqa · ORGOVYX · OXLUMO · Olympus · POSLUMA · PROLARIS · PROVENGE · Prolaris · Prolia · REZUM · SPACEOAR · SPACEOAR VUE · SPEEDICATH · TIEMANN · TISSEEL · Thiola · UROLIFT · UroLift · UroLift System · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xtandi · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
727
Per 100K population
44.7
County median income
$104,553
Nearest hospital
MOUNT SINAI WEST
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Stark is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Stark experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Stark performed 513 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Stark receive payments from pharmaceutical companies?
Yes. Dr. Stark received a total of $3,832 from 41 companies across 172 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Stark's costs compare to other urology physicians in New York?
Dr. Stark's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Stark) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in New York
Browse urology physicians in New York ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology